Unlocking Disease Potential: The Role of 7-(Trifluoromethyl)indoline-2,3-dione in Research
The landscape of medical research is constantly evolving, driven by the discovery and application of novel chemical compounds. Among these, 7-(Trifluoromethyl)indoline-2,3-dione, identified by its CAS number 391-12-8, has emerged as a compound of significant interest, particularly within the pharmaceutical sector. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying this critical research chemical.
This unique indole derivative is recognized for its potent inhibitory properties against key biological targets: COX-1, COX-2, and β-catenin. These targets are intrinsically linked to the pathogenesis of several debilitating diseases, making 7-(Trifluoromethyl)indoline-2,3-dione a valuable tool for researchers. Its application is particularly noted in the ongoing efforts to understand and potentially treat lung cancer, diabetes, and Alzheimer's disease.
In the realm of oncology, the inhibition of COX-1 and COX-2 enzymes by 7-(Trifluoromethyl)indoline-2,3-dione offers a promising avenue for exploring new therapeutic strategies against lung cancer. Researchers are investigating how modulating these pathways can impact tumor growth and progression. For those seeking to buy this chemical for cancer research, NINGBO INNO PHARMCHEM CO.,LTD. provides a reliable source.
The compound's involvement in pathways relevant to diabetes is also a key area of study. The intricate relationship between COX enzymes and insulin resistance makes this indole derivative a subject of interest for scientists aiming to develop novel diabetes management approaches. Access to quality pharmaceutical intermediates like this is crucial for such research.
Furthermore, research into Alzheimer's disease is exploring the role of β-catenin in neurodegenerative processes. As an inhibitor of β-catenin, 7-(Trifluoromethyl)indoline-2,3-dione presents a potential avenue for mitigating neuroinflammation and neurodegeneration associated with this condition. The price and availability of such specific compounds directly impact the pace of discovery.
NINGBO INNO PHARMCHEM CO.,LTD., as a dedicated supplier and manufacturer in China, ensures that researchers have access to high-quality 7-(Trifluoromethyl)indoline-2,3-dione. This commitment to quality and reliability supports the critical work being done in disease research and pharmaceutical development worldwide. For those looking to purchase this advanced chemical inhibitor, understanding its potential applications is the first step.
This unique indole derivative is recognized for its potent inhibitory properties against key biological targets: COX-1, COX-2, and β-catenin. These targets are intrinsically linked to the pathogenesis of several debilitating diseases, making 7-(Trifluoromethyl)indoline-2,3-dione a valuable tool for researchers. Its application is particularly noted in the ongoing efforts to understand and potentially treat lung cancer, diabetes, and Alzheimer's disease.
In the realm of oncology, the inhibition of COX-1 and COX-2 enzymes by 7-(Trifluoromethyl)indoline-2,3-dione offers a promising avenue for exploring new therapeutic strategies against lung cancer. Researchers are investigating how modulating these pathways can impact tumor growth and progression. For those seeking to buy this chemical for cancer research, NINGBO INNO PHARMCHEM CO.,LTD. provides a reliable source.
The compound's involvement in pathways relevant to diabetes is also a key area of study. The intricate relationship between COX enzymes and insulin resistance makes this indole derivative a subject of interest for scientists aiming to develop novel diabetes management approaches. Access to quality pharmaceutical intermediates like this is crucial for such research.
Furthermore, research into Alzheimer's disease is exploring the role of β-catenin in neurodegenerative processes. As an inhibitor of β-catenin, 7-(Trifluoromethyl)indoline-2,3-dione presents a potential avenue for mitigating neuroinflammation and neurodegeneration associated with this condition. The price and availability of such specific compounds directly impact the pace of discovery.
NINGBO INNO PHARMCHEM CO.,LTD., as a dedicated supplier and manufacturer in China, ensures that researchers have access to high-quality 7-(Trifluoromethyl)indoline-2,3-dione. This commitment to quality and reliability supports the critical work being done in disease research and pharmaceutical development worldwide. For those looking to purchase this advanced chemical inhibitor, understanding its potential applications is the first step.
Perspectives & Insights
Logic Thinker AI
“These targets are intrinsically linked to the pathogenesis of several debilitating diseases, making 7-(Trifluoromethyl)indoline-2,3-dione a valuable tool for researchers.”
Molecule Spark 2025
“Its application is particularly noted in the ongoing efforts to understand and potentially treat lung cancer, diabetes, and Alzheimer's disease.”
Alpha Pioneer 01
“In the realm of oncology, the inhibition of COX-1 and COX-2 enzymes by 7-(Trifluoromethyl)indoline-2,3-dione offers a promising avenue for exploring new therapeutic strategies against lung cancer.”